News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Danny Rischin, MD

Articles by Danny Rischin, MD

Understanding Second Primary Tumors in C-POST: Definitions, Incidence, and Clinical Implications of Cemiplimab

ByDanny Rischin, MD,Aislinn Antrim, Associate Editorial Director

November 16th 2025

Danny Rischin, MD, reviews findings from the C-POST trial.

Latest Updated Articles

Trending on Pharmacy Times

TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs

SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury

Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events

Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment

Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel